- Home
- VERA vs REVG Comparison
VERA vs REVG Comparison
Compare VERA & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- REVG
- Stock Information
- Founded
- VERA 2016
- REVG 2008
- Country
- VERA United States
- REVG United States
- Employees
- VERA N/A
- REVG N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- REVG Auto Manufacturing
- Sector
- VERA Health Care
- REVG Consumer Discretionary
- Exchange
- VERA Nasdaq
- REVG Nasdaq
- Market Cap
- VERA 2.0B
- REVG 2.2B
- IPO Year
- VERA 2021
- REVG 2017
- Fundamental
- Price
- VERA $20.86
- REVG $43.74
- Analyst Decision
- VERA Buy
- REVG Hold
- Analyst Count
- VERA 8
- REVG 4
- Target Price
- VERA $64.63
- REVG $41.25
- AVG Volume (30 Days)
- VERA 2.9M
- REVG 880.5K
- Earning Date
- VERA 08-07-2025
- REVG 06-04-2025
- Dividend Yield
- VERA N/A
- REVG 0.55%
- EPS Growth
- VERA N/A
- REVG N/A
- EPS
- VERA N/A
- REVG 1.86
- Revenue
- VERA N/A
- REVG $2,331,500,000.00
- Revenue This Year
- VERA N/A
- REVG $3.60
- Revenue Next Year
- VERA N/A
- REVG $6.89
- P/E Ratio
- VERA N/A
- REVG $23.48
- Revenue Growth
- VERA N/A
- REVG N/A
- 52 Week Low
- VERA $18.53
- REVG $21.54
- 52 Week High
- VERA $51.61
- REVG $46.10
- Technical
- Relative Strength Index (RSI)
- VERA 43.65
- REVG 64.17
- Support Level
- VERA $20.37
- REVG $43.53
- Resistance Level
- VERA $23.14
- REVG $44.99
- Average True Range (ATR)
- VERA 1.70
- REVG 1.31
- MACD
- VERA -0.46
- REVG -0.08
- Stochastic Oscillator
- VERA 3.88
- REVG 75.52
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.